Traders should monitor the upcoming earnings release and call for revenue, EPS, and guidance updates, particularly given the company's small market cap of $9M and history of volatility around financial disclosures.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 11 $6.68entry
- T+1 · 8mo ago −0.60%α +0.89% · $6.64
- T+5 · 8mo ago +0.60%α +2.79% · $6.72
- T+20 · 7mo ago −0.90%α −1.42% · $6.62
- T+60 · 6mo ago +8.98%α −2.54% · $7.28
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Lifeward Ltd. announced it will release its Q4 and full-year 2025 financial results on March 18, 2026, followed by a conference call. The press release contains no actual financial data, only logistical details for the earnings announcement.
Key Facts
- Lifeward will release Q4 and full-year 2025 financial results on March 18, 2026, before market open.
- Management will host a conference call at 8:30 a.m. EST to discuss results.
- No financial figures or guidance were disclosed in this announcement.
- The company operates in the U.S., Israel, and Germany, with a portfolio of medical rehabilitation technologies.
Financial Impact
None disclosed, actual financials expected on March 18
Risk Factors
- Limited liquidity and high volatility risk due to very small market capitalization ($9M).
- Potential for negative reaction if financial results miss expectations or guidance is weak.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3253324 |
Track record
25 reports on LFWD
7 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +20.27% at T+60 after the Aug 14, 2026 report. 9 of 9 went positive at some point.
Filters
- Nov 13, 20263d ago Press Release Bearish 6/10 Entry $4.06 Now $3.62 +10.84% settles Nov 20
- Nov 12, 20264d ago 3 Neutral 1/10 Entry $4.06 Now $3.62 −10.84% settles Nov 20
- Nov 3, 202613d ago 3 Neutral 2/10 Entry $6.06 to $5.76 Now $3.62 −40.26% ▼ −4.95% −4.04% vs SPY
- Oct 27, 202620d ago 8-K Neutral 2/10 Entry $6.04 to $5.83 Now $3.62 −40.07% ▼ −3.48% −1.49% vs SPY
- Oct 8, 20265w ago 8-K Bearish 5/10 Entry $6.49 to $6.00 Now $3.62 +44.22% ▲ +7.55% +5.58% vs SPY
- Oct 1, 20266w ago 8-K Neutral 2/10 Entry $5.96 to $6.43 Now $3.62 −39.26% ▲ +7.89% +6.58% vs SPY
- Sep 25, 20267w ago DEF 14A Bearish 7/10 Entry $6.92 to $6.67 Now $3.62 +47.69% ▲ +3.61% +4.82% vs SPY
- Aug 14, 202613w ago 8-K Mixed 6/10 No price data
- Aug 14, 202613w ago Press Release Bearish 6/10 Entry $7.45 to $7.32 Now $3.62 +51.41% ▲ +1.75% +0.38% vs SPY
- Aug 11, 202614w ago EFFECT Bearish 7/10 Entry $7.57 to $7.41 Now $3.62 +52.15% ▲ +2.08% +1.67% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers